Concepedia

Publication | Open Access

Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma

DOIFull Paper Access

196

Citations

18

References

2006

Year

François Boué, Jean Gabarre, Christian Gisselbrecht, Jacques Reynes, Antoine Chéret, Fabrice Bonnet, Éric Billaud, Martine Raphaël, Rémi Lancar, Dominique Costagliola
Journal of Clinical Oncology

Abstract

Rituximab adjunction to CHOP produced a CR rate of 77% and a 2-year survival rate of 75% in patients with AIDS-related non-Hodgkin's lymphoma, without increasing the risk of life-threatening infections.

References

YearCitations

Page 1